329 related articles for article (PubMed ID: 17980561)
1. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
Hombach J; Hoyer H; Bernkop-Schnürch A
Eur J Pharm Sci; 2008 Jan; 33(1):1-8. PubMed ID: 17980561
[TBL] [Abstract][Full Text] [Related]
2. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
Krauland AH; Guggi D; Bernkop-Schnürch A
J Control Release; 2004 Mar; 95(3):547-55. PubMed ID: 15023465
[TBL] [Abstract][Full Text] [Related]
3. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
Palmberger TF; Hombach J; Bernkop-Schnürch A
Int J Pharm; 2008 Feb; 348(1-2):54-60. PubMed ID: 17716840
[TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.
Föger F; Schmitz T; Bernkop-Schnürch A
Biomaterials; 2006 Aug; 27(23):4250-5. PubMed ID: 16618504
[TBL] [Abstract][Full Text] [Related]
5. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide.
Iqbal J; Shahnaz G; Perera G; Hintzen F; Sarti F; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2012 Jan; 80(1):95-102. PubMed ID: 21964316
[TBL] [Abstract][Full Text] [Related]
6. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
Kafedjiiski K; Hoffer M; Werle M; Bernkop-Schnürch A
Biomaterials; 2006 Jan; 27(1):127-35. PubMed ID: 16045983
[TBL] [Abstract][Full Text] [Related]
7. In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein.
Föger F; Hoyer H; Kafedjiiski K; Thaurer M; Bernkop-Schnürch A
Biomaterials; 2006 Dec; 27(34):5855-60. PubMed ID: 16919723
[TBL] [Abstract][Full Text] [Related]
8. Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor.
Iqbal J; Hombach J; Matuszczak B; Bernkop-Schnürch A
J Control Release; 2010 Oct; 147(1):62-9. PubMed ID: 20603165
[TBL] [Abstract][Full Text] [Related]
9. Thiolated hydroxyethylcellulose: synthesis and in vitro evaluation.
Sarti F; Staaf A; Sakloetsakun D; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2010 Nov; 76(3):421-7. PubMed ID: 20833249
[TBL] [Abstract][Full Text] [Related]
10. Thiolated chitosans: useful excipients for oral drug delivery.
Werle M; Bernkop-Schnürch A
J Pharm Pharmacol; 2008 Mar; 60(3):273-81. PubMed ID: 18284806
[TBL] [Abstract][Full Text] [Related]
11. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system.
Bernkop-Schnürch A; Guggi D; Pinter Y
J Control Release; 2004 Jan; 94(1):177-86. PubMed ID: 14684281
[TBL] [Abstract][Full Text] [Related]
12. Role of sulfhydryl groups in transfection? A case study with chitosan-NAC nanoparticles.
Loretz B; Thaler M; Bernkop-Schnürch A
Bioconjug Chem; 2007; 18(4):1028-35. PubMed ID: 17552491
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of a chitosan-N-acetyl cysteine conjugate.
Schmitz T; Grabovac V; Palmberger TF; Hoffer MH; Bernkop-Schnürch A
Int J Pharm; 2008 Jan; 347(1-2):79-85. PubMed ID: 17681439
[TBL] [Abstract][Full Text] [Related]
14. Improved synthesis of quaternary ammonium-chitosan conjugates (N+ -Ch) for enhanced intestinal drug permeation.
Zambito Y; Zaino C; Uccello-Barretta G; Balzano F; Di Colo G
Eur J Pharm Sci; 2008 Apr; 33(4-5):343-50. PubMed ID: 18296036
[TBL] [Abstract][Full Text] [Related]
15. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine.
Werle M; Hoffer M
J Control Release; 2006 Mar; 111(1-2):41-6. PubMed ID: 16377016
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
[TBL] [Abstract][Full Text] [Related]
17. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
[TBL] [Abstract][Full Text] [Related]
18. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and evaluation of thiolated quaternary ammonium-chitosan conjugates for enhanced intestinal drug permeation.
Zambito Y; Fogli S; Zaino C; Stefanelli F; Breschi MC; Di Colo G
Eur J Pharm Sci; 2009 Sep; 38(2):112-20. PubMed ID: 19576984
[TBL] [Abstract][Full Text] [Related]
20. S-preactivated thiolated glycol chitosan useful to combine mucoadhesion and drug delivery.
Perrone M; Lopalco A; Lopedota A; Cutrignelli A; Laquintana V; Franco M; Bernkop-Schnürch A; Denora N
Eur J Pharm Biopharm; 2018 Nov; 132():103-111. PubMed ID: 30253185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
